Launch your careeer in Biotherapeutics
DIABETES is a chronic disease affecting approximately 415 million people worldwide, with almost a quarter of a million of those in Ireland. Currently €1.35 billion (or about 10% of the total annual Irish healthcare budget) is being expended on diabetes care with severe complications including blindness, heart disease, kidney failure, and limb amputations.
Sean Kirwan, a recent graduate of MSc in Biotechnology and also BSc in Pharmacology in UCD, is carrying out a Knowledge Exchange Dissemination Scheme (KEDS) funded by the Health Research Board (HRB) in collaboration with UCD and ICON plc. ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical devices industries.
The project involves increasing awareness for diabetes and blindness associated with diabetes. Sean is currently working with Firecrest (a division of ICON plc based in Limerick), creating 3D animated videos based on diabetes. These videos are designed to target a wide range of audiences including patients, students and laypeople interested in learning about diabetes and their related complications.
Firecrest strives to enhance patient engagement and support patient recruitment and retention in clinical studies. Sean works as part of the Mechanism of Action (MOA) team in Firecrest which comprises of Pharmacologists working in parallel with 3D Graphic Designers to create and design award-winning, user-friendly drug and disease overview videos.